11 March 2016

mRNA Therapies: Now and Next

Organised by:

SCI's Biotechnology Group in partnership with the University of Westminster

University of Westminster

Registration Closed

This event is no longer available for registration.

Synopsis
mRNA therapies have attracted significant interest in the last few years. CureVac has been active in this field for over 15 years and has applied its mRNA platform to cancer immunotherapy and prophylactic vaccines, and is now exploring the immense potential of molecular therapy. Dr Horschcroft will presen some of his CureVac's preclincal data and give a glimpse of where they are heading next.
Programme

Day 1 - 11 March 2016

Event Schedule
13:00
Event starts

Venue and Contact

University of Westminster

School of Life Sciences
115 New Cavendish Street
London W1W 6UW

Please click here for a location map.

 

SCI Communications Team

Tel: +44 (0) 20 7598 1594

Email: communications@soci.org


Fees
This is a free event, no need to book. Please check this page for any updates or changes before attending the event.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Partners

Additional Info

For more information, please contact:

SCI

Speaker

Dr Nigel Horschcroft, Director, Alliance Management, CureVac AG (Germany)

Related Events